
Simone Krebs Laboratory
@labkrebs
We focus on the development of imaging and theranostic agents including in vivo tracking methods of adoptively transferred cells for cancer therapy.
ID: 1522428036196577282
https://www.mskcc.org/research-areas/labs/simone-krebs 06-05-2022 04:08:34
16 Tweet
92 Followers
112 Following

Fantastic talk by Emma Reynaud wrapping up months of amazing work imaging CAR T cells in action diagnosing & treating cancers Memorial Sloan Kettering Cancer Center Simone Krebs Laboratory Scheinberg Lab Jan Jacob Schuringa Larsonlab #theranostics


Simone Krebs Laboratory Huge congratulations to Laura Eibler for receiving the 1st Place price in Basic Track for her abstract & 1st Place Center for Molecular Imaging Innovation & Translation Young Investigator Award at the SNMMI 2022!! And kudos to the entire team! Scheinberg Lab Larson Lab


Simone Krebs Laboratory We have an open postdoc position. Are you interested in molecular imaging and therapy (theranostic) and adoptive T cell therapy? Motivated to work in a highly interactive, interdisciplinary and rewarding environment? Then check us out! mskcc.org/research-areas…

Using blood-based #biomarkers to determine the efficacy of ¹⁷⁷Lu-DOTATATE in #NeuroendocrineTumors. ow.ly/4PAF50NAttU #NuclearMedicine #MedicalResearch #NETCancer Lisa Bodei, MD, PhD Diane Reidy-Lagunes Simone Krebs Laboratory Audrey Mauguen Richard K.G. Do


⁶⁸Ga-pentixafor PET may guide CXCR4-based theranostic approaches with pentixather in selected #meningioma. ow.ly/bZKY50NAtB9 #PETscan #Theranostics Simone Krebs Laboratory



Our paper is out! We present a versatile platform enabling monitoring of CAR-T cells in vivo using PET, as well as providing selective delivery of therapeutic radioisotopes to increase anti-tumor efficacy. Great team work! Scheinberg Lab thno.org/v13p5469.htm #Theranostics




Dr. Simone Krebs Simone Krebs Laboratory winning the Saul Hertz Young Investigator Award at Theranostics 2024. Memorial Sloan Kettering Cancer Center #theranostics #TWC2014




The Illustrated Post: Symptomatic PSMA PET–positive radionecrosis after multimodality brain metastasis–directed treatment including ¹⁷⁷Lu-PSMA-617. ow.ly/5sra50Vjv05 #RPTherapy #NuclearMedicine #BrainMetastases Simone Krebs Laboratory Brandon Imber @mskCancerCenter
